Vimarsana
Biggest News Aggregation in the World

Page 20 - Stock Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stock Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stock Code Today - Breaking & Trending Today

"CabCab," the First Certified Smart Taxi Metre Launches Pilot with 100 Taxis - Vimarsana News

"CabCab," the First Certified Smart Taxi Metre Launches Pilot with 100 Taxis

HONG KONG SAR - Media OutReach Newswire - 31 January 2024 - With the dawn of the New Retail Era, there has been a significant uptick in the use of electronic

"CabCab," the First Certified Smart Taxi Metre Launches Pilot with 100 Taxis | Taiwan News - Vimarsana News

"CabCab," the First Certified Smart Taxi Metre Launches Pilot with 100 Taxis | Taiwan News

"CabCab," the First Certified Smart Taxi Metre Launches Pilot with 100 Taxis | 2024-01-31 17:25:00

Hang Lung Group and Hang Lung Properties Appoint Mr. Adriel Chan as New Chair - Vimarsana News

Hang Lung Group and Hang Lung Properties Appoint Mr. Adriel Chan as New Chair

<p>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach Newswire</a> - 30 January 2024 - Hang Lung Group Limited (Stock Code: 00010) and Hang Lung Properties Limited (Stock Code: 00101) today announced the retirement of Mr.</p>

Asieris Presents for the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU - Vimarsana News

Asieris Presents for the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU

SHANGHAI, Jan. 29, 2024 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering,

Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU - Vimarsana News

Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU

/PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and...